Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Anglo-French Drugs & Industries Limited, is an unlisted public company incorporated on 01 February, 1923. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 2.00 cr and the total paid-up capital is INR 1.23 cr.
Anglo-French Drugs & Industries Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 606.36% over the previous year. At the same time, it's book networth has increased by 1032.45%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
-7.13%
-106.46%
-18.17%
-65.39%
-19.52%
3.72
27.83
-185.78
-98.65
10.44
-0.07
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(24)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 30.0 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 13.7 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 0.1 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Abhay Kanoria | 00108894 | 28 years |
| Whole-time Director | Uddhav Abhay Kanoria | 00108909 | 18 years |
| Whole-time Director | Nirbhay Abhay Kanoria | 02558300 | 0 years |
| Director | Pradeep Joshi | 02713934 | 1 years |
| Director | Rohit Choraria | 07003583 | 2 years |
| Director | Rakesh Parmeshwar Kanyadi | 08532438 | 5 years |
| Director | Srinivasan Krishnan | 08709528 | 1 years |
| Director | Rani Shokeen | 10634071 | 1 years |
| Kmp | Manee Sriee Aneetha | <HIDDEN> | 2 years |
| Kmp | Manik Kumar Singh | <HIDDEN> | 0 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| BROACH TEXTILE MILLS LIMITED (FULLFLEDGED PUBLIC CO ) |
Active
|
8.9 Cr | 2 | Maharashtra |
| RADHA KESARI SPINNING MILLS LIMITED |
Active
|
8.5 L | 1 | Gujarat |
| SUDARSHAN EXPORTS LTD |
Strike Off
|
49.5 L | 1 | West Bengal |
| THAMES LINERS LTD |
Strike Off
|
24.5 L | 1 | West Bengal |
| BROACH PROCESSORS PVT LTD |
Amalgamated
|
50.5 L | 2 | Maharashtra |
| TIRUPATI PRINTERS PVT LTD |
Amalgamated
|
50.5 L | 2 | Maharashtra |
| SUDARSHAN EXPORTS LIMITED |
Active
|
32.8 L | 2 | Maharashtra |
| EKTA TIE-UP PRIVATE LIMITED |
Active
|
1.6 Cr | 2 | Maharashtra |
| SHRI BINOD KANORIA FOUNDATION |
Active
|
10,000.0 | 2 | Maharashtra |
| PARITOSH INDUSTRIAL FINANCE LIMITED |
Amalgamated
|
50.0 L | 1 | Maharashtra |
| ENTREPRENEURS' ORGANIZATION MUMBAI |
Active
|
0.0 | 1 | Maharashtra |
| AFD PHARMA PRIVATE LIMITED |
Active
|
17.0 L | 1 | Maharashtra |
| BALA MANDIR FOUNDATION |
Active
|
0.0 | 1 | Tamil Nadu |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Anglo French Drugs & Industries Pte. Ltd. | Singapore | - | - |
The incorporation date of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is 01 February, 1923
The authorized share capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is INR ₹ 2.0 Cr.
The paid-up capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is INR ₹ 1.2 Cr.
The registered address of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is Plot No.4 Phase II, Peenya Industrial Area, Peenya Peenya Sm all Industries Bangalore North Bangalore Karnataka - 560058
The CIN number of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is L24230KA1923PLC010205.
Expand
Delete
Collapse
See
details
